Pharmacist-Assisted Medication Transition for Care Transitions
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether involving a clinical pharmacist can improve the transition from a hospital to a skilled nursing facility. The goal is to determine if the pharmacist can reduce medication-related problems during this transition. The study includes two groups: one receives assistance from a pharmacist through the Pharmacy Integrated Transitions (PIT) program, while the other follows the usual discharge process. Individuals recently hospitalized at one of several University of Washington medical centers and moving to a participating nursing facility may be suitable candidates, especially if they frequently experience medication changes.
As an unphased trial, this study provides a unique opportunity to enhance medication safety during care transitions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on the role of a pharmacist in managing medication transitions, so it's best to ask the trial coordinators for more details.
What prior data suggests that the Pharmacy Integrated Transitions (PIT) program is safe?
Research has shown that involving pharmacists when patients transition between care settings helps reduce medication errors. These errors can lead to medication-related problems. One study found that pharmacists played a crucial role in enhancing medication safety when patients moved from hospitals to other care facilities. This finding suggests that programs like the Pharmacy Integrated Transitions (PIT) program can enhance patient safety.
No specific safety concerns exist regarding the PIT program itself. The primary goal is to ensure proper medication management during these transitions. This approach aims to prevent harmful events and improve overall patient care.12345Why are researchers excited about this trial?
Researchers are excited about the Pharmacist-Assisted Medication Transition because it offers a hands-on approach to managing patient care during hospital-to-nursing facility transitions. Unlike the standard discharge process, which often leaves gaps in medication management, this program involves a clinical pharmacist who actively reviews and adjusts medications, ensuring a smoother transition. By fostering better communication between hospital and nursing facility teams, this approach aims to reduce medication errors and improve patient outcomes, making it a promising advancement in transitional care.
What evidence suggests that the Pharmacy Integrated Transitions (PIT) program is effective for decreasing medication-related problems during care transitions?
Research has shown that the Pharmacy Integrated Transitions (PIT) program, tested in this trial, helps patients transition more smoothly from hospitals to skilled nursing facilities (SNFs). In this trial, some participants will receive assistance from a clinical pharmacist during their transition, which includes a comprehensive medication review and structured handoff between clinical teams. Studies have found that pharmacist-led medication reviews reduce the chances of patients returning to the hospital and lower their stress by addressing medication safety. Evidence also suggests that these pharmacy services decrease medication-related issues during transitions. Overall, involving pharmacists in the transition from hospitals to SNFs improves patient outcomes.12678
Who Is on the Research Team?
Giana Davidson, MD MPH
Principal Investigator
University of Washington
Are You a Good Fit for This Trial?
This trial is for adults over 18 transitioning from certain hospitals to independent skilled nursing facilities. It's not for those under 18 or patients moving to hospice care.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Transition
A clinical pharmacist conducts a comprehensive medication review, including medication reconciliation, adjustment, and monitoring during the transitional period from hospital to SNF, along with a structured handoff between clinical teams.
Follow-up
Participants are monitored for medication-related problems, readmissions, and deaths within 30 days post hospital discharge.
What Are the Treatments Tested in This Trial?
Interventions
- Pharmacy Integrated Transitions (PIT) program
Trial Overview
The study tests a Pharmacy Integrated Transitions program where a clinical pharmacist helps manage medication during the move from hospital to skilled nursing facility, using a crossover randomized control design.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
A clinical pharmacist will be provided as a patient discharges from one of four University of Washington (UW) medical centers to one of 14 post acute skilled nursing facilities randomized to the intervention arm. The coordinating transitional pharmacist will conduct (1) a comprehensive medication review including medication reconciliation, adjustment, and monitoring during the transitional period from hospital to SNF, 2) a structured handoff between clinical teams at the hospital and SNF.
Patient will transition from one of four University of Washington (UW) medical centers to one of 14 post-acute skilled nursing facilities randomized to the control arm. Patients will receive the standard discharge process.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborator
Published Research Related to This Trial
Citations
Pharmacy Integrated Transitions (PIT) trial: a protocol for a ...
The PIT trial aims to evaluate the effectiveness of the PIT programme in improving patients' care transitions from hospitals to SNFs compared with usual care.
a protocol for a pragmatic cluster-randomised crossover trial
The PIT trial aims to evaluate the effectiveness of the PIT programme in improving patients' care transitions from hospitals to SNFs compared with usual care.
Effectiveness of pharmacist-led medication reconciliation on ...
This pragmatic, prospective, controlled trial evaluated the effectiveness of routine pharmacist-led medication reconciliation compared to standard care on ...
4.
digital.ahrq.gov
digital.ahrq.gov/2020-year-review/research-summary/improving-care-transitions-hospitalized-patients-pharmacy-integrated-transitions-programImproving Care Transitions of Hospitalized Patients With the ...
The PIT program shows promise to reduce hospital readmissions, lessen patient emotional distress by proactively addressing medication safety.
Effectiveness of digital platform in reducing unintentional ...
Conclusions. Medication reconciliation using the MedBook Portal effectively reduces UMDs during the transition of care from hospital discharge ...
6.
psnet.ahrq.gov
psnet.ahrq.gov/issue/effect-transitional-pharmaceutical-care-program-occurrence-ades-after-discharge-hospitalThe effect of a transitional pharmaceutical care program on ...
Pharmacists play a critical role in medication safety during transitions of care. This multi-center study found that a transitional pharmacy care program ...
7.
pharmacytimes.com
pharmacytimes.com/view/pharmacists-strengthen-transitions-of-care-to-improve-patient-outcomesPharmacists Strengthen Transitions of Care to Improve ...
Pharmacists play an important role in transitions of care by ensuring medication safety and effectiveness during patient movement between care ...
8.
outcomes.com
outcomes.com/blog/payer/pharmacists-provide-critical-interventions-during-transitions-of-carePharmacists Provide Critical Interventions During ...
Outcomes receives a notification of a patient's discharge. Outcomes provides an alert within the OutcomesOne platform to notify the pharmacist.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.